CVC Joins EQT In Pursuit Of AUB Group (AUB AU)
On the 28th October 2025, AUB Group Limited (AUB AU), an insurance “matchmaker”, announced a NBIO, via a Scheme, from EQT at A$45/share, a ~40% premium to undisturbed.
The share price has consistently traded wide to terms, not just because of the transactions’ indicative nature; but EQT’s track record on progressing from indicative to firm is not optimum.
This morning AUB announced CVC was teaming up with EQT, at $45/share; and concurrently requested additional due diligence. This has been granted by AUB.
The Trade:
Terms are attractive.
Yes - indicative. However, the advent of CVC adds a veneer of confidence terms may be firmed.
I’d look to enter around here and on weakness.
This insight is labelled bullish as I’m not bearish here.
Keep reading with a 7-day free trial
Subscribe to Aussie/Kiwi M&A/Events to keep reading this post and get 7 days of free access to the full post archives.

